Search for: "State v. Lilly" Results 81 - 100 of 717
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jan 2009, 2:22 pm
The Lilly Ledbetter Fair Pay Act was initiated by Congress in reaction to the United States Supreme Court’s 2007 decision in Ledbetter v. [read post]
29 Sep 2018, 8:09 pm by Patent Docs
True Health Diagnostics LLC -- Eli Lilly & Co. v. [read post]
7 Jun 2019, 11:33 am by IPWatchdog
This week in Other Barks & Bites: the Wisconsin Alumni Research Foundation's petition to the Supreme Court in a case against Apple; AAG Makan Delrahim's remarks about misuse of antitrust law by U.S. courts; Eli Lilly's petition to the Supreme Court regarding functional claiming rule; cert granted in Allen v. [read post]
7 Jun 2019, 11:33 am by IPWatchdog
This week in Other Barks & Bites: the Wisconsin Alumni Research Foundation's petition to the Supreme Court in a case against Apple; AAG Makan Delrahim's remarks about misuse of antitrust law by U.S. courts; Eli Lilly's petition to the Supreme Court regarding functional claiming rule; cert granted in Allen v. [read post]
8 Sep 2008, 7:52 pm
Eli Lilly & Co. back to West Virginia state courts on Tuesday, September 9. [read post]
19 Jan 2018, 3:58 am
Readers interested in patent law will be familiar with last summer's decision of the UK Supreme Court in Actavis v Eli Lilly [2017] UKSC 48. [read post]
10 Mar 2010, 3:51 pm
The Federal Circuit’s December 7, 2009 hearing of oral argument in Ariad v. [read post]
8 Apr 2014, 1:17 pm by Dr. Shezad Malik
Takeda and Lilly face hundreds more claims over Actos in state courts including Nevada and Illinois. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]